It is probable that chronic low-grade inflammation linked with ApoE4 puts the brain into a vulnerable state for the development of AD (Table 3), but the brain of ApoE2 carriers is resilient to the influence of chronic low-grade inflammation on the development of AD. Here, APOE is linked to Alzheimer disease.